Spreading alpha-synuclein oligomers trigger astrocyte/microglial changes and astrocyte-glutamatergic neuron system dysfunction in an age-related manner
A model in which α-syn oligomer spreading, amplified by aging, simultaneously disrupts the astrocyte–glutamatergic neuron axis and drives microglia into a senescent DAM-like state is proposed, and candidate gene sets for both processes are provided for further investigation of glial dysfunction in PD.
Abstract
Parkinson’s disease (PD) is characterized by the progressive accumulation and spatio-temporal spread of α-synuclein (α-syn) oligomers and a progressive loss of dopaminergic neurons. Many studies showed a direct cytotoxic effect of α-syn oligomers on neurons. Other cell types including astrocytes or microglia were also reported to show specific responses to α-syn and are believed to play a role in the spreading of PD pathology. To investigate the transcriptional and cellular consequences of α-syn oligomer spreading, we employed spatial transcriptomics, single-nucleus RNA sequencing (snRNA-seq), and bulk RNA sequencing (bRNA) of isolated microglia in a transgenic PD mouse model expressing human α-syn in neurons. We further compared our findings to published public snRNA-seq datasets from human PD patients. Our analysis identified a transcriptional “Spreading Signature” associated with α-syn pathology in the substantia nigra in our PD mouse model. We found an age correlated increase in astrocytes, close interactions between astrocytes and α-syn, and transcriptional dysregulation of the astrocyte-glutamatergic neuron axis. We further identified two subtypes of glutamatergic neurons that are vulnerable to astrocytic changes. The surviving microglial population shifted towards a senescent, disease-associated microglia (DAM)-like state with enhanced phagocytic, lysosomal, and motile signatures, and the accumulation of swollen lysosomal pockets. Astrocytic and microglial changes, including diminished neuronal signaling, were partly concordant between mouse and human SN datasets. Based on our results, we propose a model in which α-syn oligomer spreading, amplified by aging, simultaneously disrupts the astrocyte–glutamatergic neuron axis and drives microglia into a senescent DAM-like state, and we provide candidate gene sets for both processes for further investigation of glial dysfunction in PD.
PrPC expression levels are identified as an important modulator of nigrostriatal vulnerability and neuroinflammatory phenotype in response to αSynO, supporting the hypothesis that PrPC contributes to αSynO-mediated pathogenic mechanisms.
Flavio de Souza Júnyor, F. Leser, Sarah de Souza Albuquerque et al.· Frontiers in Neuroscience· 0 citations
Parkinson's disease (PD) and related synucleinopathies are marked by the accumulation and propagation of α-synuclein (α-syn) aggregates, a process primarily studied in neurons. Whether astrocytes actively contribute to α-syn processing and intercellular transfer remains unclear. Here, using a physiologically relevant n...
Hiroshi Hanafusa, Kota Ohashi, Hiromu Shojima et al.· EMBO Reports· 0 citations
Interestingly, amplified material from MSA brains induced significantly more oligodendroglial pSyn aggregates than amplified material from PD brains, and mice injected with the fibril polymorph, showed mild changes in microglial reactivity.
Anne-Line Strange Laursen, K. Willén, Alexis Fenyi et al.· Neurobiology of Disease· 0 citations
The deleterious effects of pS129 accumulation are demonstrated and a toxic role played by these aggregates are argued in favor of a toxic role played by these aggregates.
Amr Eed, Vladislav Novikov, Shahrzad Bahrampour et al.· bioRxiv· 0 citations
This review synthesises current evidence on how mutations in Leucine-Rich Repeat Kinase 2 (LRRK2), the most common genetic cause of familial PD, fundamentally corrupt glial handling of extracellular α-synuclein and evaluates emerging therapeutic strategies targeting LRRK2 kinase activity, NLRP3 inflammasome activation,...
Indrani Datta, Dibyam Debasish Sahu· Advances in Immunology· 0 citations
This study identifies a subtype of human microglia capable of removing intraneuronal aggregates and potential therapeutic targets and identifies a cluster of disease-associated microglia responsible for this beneficial phenotype and the Parkinson's disease GWAS candidate glycoprotein nonmetastatic melanoma protein B (G...
Hung-Ju Chueh, Antigoni Katsikoudi, Ana Aragón-González et al.· Science Translational Medici...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.